Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ: SNDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 17.03 0.00%
SNDX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.52B
- EPS (TTM)
- -$2.45
- Dividend yield
- None
- 52-week range
- 12.99 – 25.59
- Day range
- 17.03 – 17.70
- Volume / Avg
- 1.59M / 1.58M
- Beta
- —
- Shares outstanding
- 89.30M
- Next earnings
- Nov 2, 2026
52-week range
SNDX stock today
On Oct 7, SNDX ended the session at $17.03, shedding $0.34 (1.96%), versus the S&P 500's 0.22% decline. Shares are 33.5% below their 52-week high of $25.59, set on Mar 25, 2026 and 31.1% above the 52-week low of $12.99, in the middle of the past year's range. SNDX is down 18.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 3.5%.
Syndax Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$2.45), so its P/E ratio is not meaningful. Syndax Pharmaceuticals's next earnings report is expected on Nov 2, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Syndax Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2016
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $-0.51
Syndax Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STOKStoke Therapeutics Inc. | 24.29 | -0.33% | $1.57B | vs SNDX |
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs SNDX |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs SNDX |
| INVAInnoviva Inc. | 21.06 | +1.10% | $1.52B | vs SNDX |
| RAPPRapport Therapeutics Inc. | 30.86 | -0.93% | $1.48B | vs SNDX |
| RAREUltragenyx Pharmaceutical Inc. | 14.89 | +2.97% | $1.47B | vs SNDX |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs SNDX |
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs SNDX |
Indexes, lists and sector
Largest Health Care stocks
Syndax Pharmaceuticals stock FAQ
What is Syndax Pharmaceuticals's stock price today?
SNDX last traded at $17.03 as of Oct 7, 4:00 PM EDT, down 1.96% on the day. Prices are delayed at least 15 minutes.
When is Syndax Pharmaceuticals's next earnings date?
Syndax Pharmaceuticals is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $-0.51.
What is the SNDX 52-week high?
The 52-week high for SNDX is $25.59 and the 52-week low is $12.99. The stock is currently 33.5% below its high.